Takeda considers selling Osaka headquarters to fund Shire purchase

Takeda Pharmaceutical Co. is considering selling its symbolic Osaka headquarters building to help finance its £46 billion ($60 billion) deal to acquire Irish drugmaker Shire Plc., sources close to the …
( read original story …)


Related Post

Nikkei faces negative week with investors wary of ...
views 297
TOKYO, Feb 17 Japan's Nikkei share average dropped...
Japan's megabanks to cut 2018 hiring class by...
views 300
TOKYO -- Just over 3,300 new college graduates are...
Japan manufacturers’ mood hits decade-high &...
views 218
Service-sector index +30 in Oct vs +34 in Sept * B...
Japan teams with Southeast Asia to protect propert...
views 46
Several newly bred Japanese strawberries and cherr...
Nagoya-led team flips the switch on ferroelectrics
views 200
Nagoya, Japan - Many next-generation electronic an...
Leading Japanese Enterprise IT Supplier Macnica Si...
views 39
REDWOOD CITY, Calif., Sept. 19, 2018 /PRNewswire/ ...
Japanese doctor named Việt Nam’s honourary consul ...
views 200
TOKYO — Japanese doctor Nagato Natsume has been ap...
Japan Display reports fourth straight quarterly lo...
views 151
TOKYO (Reuters) - Japan Display Inc reported on We...
Large earthquake strikes off Fukushima in Japan
views 225
TOKYO -- An earthquake with magnitude of 6.9 struc...
Sharp in legal battle with Hisense over patents as...
views 193
The Osaka-based Sharp plans to be more assertive w...